Is Annexon, Inc. (ANNX) a Buy, Sell, or Hold?
Annexon, Inc.
NASDAQ:ANNX
$6.5 USD
$0.95 (17.12%)
- Volume
- 8.74M
- Average Volume
- 3.26M
- Market Capitalization
- $777.37M
- P/E Ratio
- -5.33
- Dividend Yield
- 0.00%
- Price Target
- $7.00
- Year High
- $7.18
- Year Low
- $2.03
- Day High
- —
- Day Low
- —
- Payout Ratio
- $-0.01
- Current Ratio
- $6.35
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
27
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
13
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 62783
ANNX Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
ANNX Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Waddill William D. | director | 2026-06-11 | A-Award | 4.7 | 2026-06-15 |
| Satter Muneer A | director | 2026-06-11 | A-Award | 4.7 | 2026-06-15 |
| JONES WILLIAM A JR | director | 2026-06-11 | A-Award | 4.7 | 2026-06-15 |
| Cockroft Bettina M. | director | 2026-06-11 | A-Award | 4.7 | 2026-06-15 |
| Choi Jung | director | 2026-06-11 | A-Award | 4.7 | 2026-06-15 |
| Carson William H. | director | 2026-06-11 | A-Award | 4.7 | 2026-06-15 |
| Yednock Ted | officer: EVP & CHIEF INNOVATION OFFICER | 2026-06-11 | M-Exempt | 1.8501 | 2026-06-15 |
| Yednock Ted | officer: EVP & CHIEF INNOVATION OFFICER | 2026-06-11 | M-Exempt | 1.8501 | 2026-06-15 |
| Satter Muneer A | director | 2026-05-28 | P-Purchase | 5.41 | 2026-05-29 |
| Carson William H. | director | 2026-05-11 | P-Purchase | 5.78 | 2026-05-13 |
| Carson William H. | director | 2026-04-10 | P-Purchase | 6.2 | 2026-04-14 |
| Carson William H. | director | 2026-03-10 | P-Purchase | 5.67 | 2026-03-12 |
| Dananberg Jamie | officer: CHIEF MEDICAL OFFICER | 2026-03-02 | S-Sale | 5.43 | 2026-03-04 |
| Overdorf Michael | officer: EVP & CHIEF BUSINESS OFFICER | 2026-03-02 | S-Sale | 5.42 | 2026-03-04 |
| Yednock Ted | officer: EVP & CHIEF INNOVATION OFFICER | 2026-03-02 | S-Sale | 5.42 | 2026-03-04 |
| ARTIS DEAN RICHARD | officer: EVP & CHIEF SCIENTIFIC OFFICER | 2026-03-02 | S-Sale | 5.43 | 2026-03-04 |
| Lew Jennifer | officer: EVP & CHIEF FINANCIAL OFFICER | 2026-03-02 | S-Sale | 5.42 | 2026-03-04 |
| Love Douglas | director, officer: PRESIDENT AND CEO | 2026-02-19 | A-Award | 5.1 | 2026-02-23 |
| Dananberg Jamie | officer: CHIEF MEDICAL OFFICER | 2026-02-19 | A-Award | 5.1 | 2026-02-23 |
| Dananberg Jamie | officer: CHIEF MEDICAL OFFICER | 2026-02-19 | A-Award | 0 | 2026-02-23 |
| Overdorf Michael | officer: EVP & CHIEF BUSINESS OFFICER | 2026-02-19 | A-Award | 5.1 | 2026-02-23 |
| Overdorf Michael | officer: EVP & CHIEF BUSINESS OFFICER | 2026-02-19 | A-Award | 0 | 2026-02-23 |
| ARTIS DEAN RICHARD | officer: EVP & CHIEF SCIENTIFIC OFFICER | 2026-02-19 | A-Award | 5.1 | 2026-02-23 |
| ARTIS DEAN RICHARD | officer: EVP & CHIEF SCIENTIFIC OFFICER | 2026-02-19 | A-Award | 0 | 2026-02-23 |
| Yednock Ted | officer: EVP & CHIEF INNOVATION OFFICER | 2026-02-19 | A-Award | 5.1 | 2026-02-23 |
| Yednock Ted | officer: EVP & CHIEF INNOVATION OFFICER | 2026-02-19 | A-Award | 0 | 2026-02-23 |
| Lew Jennifer | officer: EVP & CHIEF FINANCIAL OFFICER | 2026-02-19 | A-Award | 5.1 | 2026-02-23 |
| Lew Jennifer | officer: EVP & CHIEF FINANCIAL OFFICER | 2026-02-19 | A-Award | 0 | 2026-02-23 |
| Dananberg Jamie | officer: CHIEF MEDICAL OFFICER | 2026-02-18 | S-Sale | 5.1 | 2026-02-20 |
| Lew Jennifer | officer: EVP & CHIEF FINANCIAL OFFICER | 2026-02-18 | S-Sale | 5.11 | 2026-02-20 |
| ARTIS DEAN RICHARD | officer: EVP & CHIEF SCIENTIFIC OFFICER | 2026-02-18 | S-Sale | 5.1 | 2026-02-20 |
| Yednock Ted | officer: EVP & CHIEF INNOVATION OFFICER | 2026-02-18 | S-Sale | 5.11 | 2026-02-20 |
| Overdorf Michael | officer: EVP & CHIEF BUSINESS OFFICER | 2026-02-18 | S-Sale | 5.1 | 2026-02-20 |
| Carson William H. | director | 2025-12-30 | P-Purchase | 5.02 | 2026-01-02 |
| Choi Jung | director | 2025-12-01 | P-Purchase | 4.19 | 2025-12-03 |
| Carson William H. | director | 2025-12-01 | P-Purchase | 4.47 | 2025-12-03 |
| Satter Muneer A | director | 2025-11-21 | P-Purchase | 4.28 | 2025-11-21 |
| Satter Muneer A | director | 2025-11-20 | P-Purchase | 4.48 | 2025-11-21 |
| Satter Muneer A | director | 2025-11-19 | P-Purchase | 3.94 | 2025-11-19 |
| Satter Muneer A | director | 2025-11-18 | P-Purchase | 3.18 | 2025-11-19 |
| Satter Muneer A | director | 2025-11-17 | P-Purchase | 2.99 | 2025-11-19 |
| Carson William H. | director | 2025-10-30 | P-Purchase | 3.17 | 2025-10-31 |
| Carson William H. | director | 2025-09-30 | P-Purchase | 3.05 | 2025-10-02 |
| Carson William H. | director | 2025-09-02 | P-Purchase | 2.09 | 2025-09-04 |
| Carson William H. | director | 2025-07-30 | P-Purchase | 2.43 | 2025-08-01 |
| Yednock Ted | officer: EVP & CHIEF INNOVATION OFFICER | 2025-07-14 | S-Sale | 2.58 | 2025-07-16 |
| Lew Jennifer | officer: EVP & CHIEF FINANCIAL OFFICER | 2025-07-14 | S-Sale | 2.58 | 2025-07-16 |
| Overdorf Michael | officer: EVP & CHIEF BUSINESS OFFICER | 2025-07-14 | S-Sale | 2.61 | 2025-07-16 |
| Carson William H. | director | 2025-06-30 | P-Purchase | 2.46 | 2025-07-01 |
| WIGGANS THOMAS G | director | 2025-06-05 | A-Award | 2.55 | 2025-06-09 |
| Satter Muneer A | director, 10 percent owner: | 2025-06-05 | A-Award | 2.55 | 2025-06-09 |
| Waddill William D. | director | 2025-06-05 | A-Award | 2.55 | 2025-06-09 |
| Carson William H. | director | 2025-06-05 | A-Award | 2.55 | 2025-06-09 |
| Choi Jung | director | 2025-06-05 | A-Award | 2.55 | 2025-06-09 |
| JONES WILLIAM A JR | director | 2025-06-05 | A-Award | 2.55 | 2025-06-09 |
| Cockroft Bettina M. | director | 2025-06-05 | A-Award | 2.55 | 2025-06-09 |
| ARTIS DEAN RICHARD | officer: EVP & CHIEF SCIENTIFIC OFFICER | 2025-02-27 | A-Award | 2.5 | 2025-03-03 |
| ARTIS DEAN RICHARD | officer: EVP & CHIEF SCIENTIFIC OFFICER | 2024-02-27 | A-Award | 0 | 2025-03-03 |
| Dananberg Jamie | officer: CHIEF MEDICAL OFFICER | 2025-02-27 | A-Award | 2.5 | 2025-03-03 |
| Dananberg Jamie | officer: CHIEF MEDICAL OFFICER | 2024-02-27 | A-Award | 0 | 2025-03-03 |
| Lew Jennifer | officer: EVP & CHIEF FINANCIAL OFFICER | 2025-02-27 | A-Award | 2.5 | 2025-03-03 |
| Lew Jennifer | officer: EVP & CHIEF FINANCIAL OFFICER | 2024-02-27 | A-Award | 0 | 2025-03-03 |
| Love Douglas | director, officer: PRESIDENT AND CEO | 2025-02-27 | A-Award | 2.5 | 2025-03-03 |
| Yednock Ted | officer: EVP & CHIEF INNOVATION OFFICER | 2025-02-27 | A-Award | 2.5 | 2025-03-03 |
| Yednock Ted | officer: EVP & CHIEF INNOVATION OFFICER | 2024-02-27 | A-Award | 0 | 2025-03-03 |
| Overdorf Michael | officer: EVP & CHIEF BUSINESS OFFICER | 2025-02-27 | A-Award | 2.5 | 2025-03-03 |
| Overdorf Michael | officer: EVP & CHIEF BUSINESS OFFICER | 2024-02-27 | A-Award | 0 | 2025-03-03 |
| Dananberg Jamie | officer: CHIEF MEDICAL OFFICER | 2025-02-18 | S-Sale | 2.96 | 2025-02-20 |
| ARTIS DEAN RICHARD | officer: EVP & CHIEF SCIENTIFIC OFFICER | 2025-02-18 | S-Sale | 2.97 | 2025-02-20 |
| Yednock Ted | officer: EVP & CHIEF INNOVATION OFFICER | 2025-02-18 | S-Sale | 2.91 | 2025-02-20 |
| Overdorf Michael | officer: EVP & CHIEF BUSINESS OFFICER | 2025-02-18 | S-Sale | 2.95 | 2025-02-20 |
| Lew Jennifer | officer: EVP & CHIEF FINANCIAL OFFICER | 2025-02-18 | S-Sale | 2.92 | 2025-02-20 |
| Love Douglas | director, officer: PRESIDENT AND CEO | 2025-02-13 | S-Sale | 2.95 | 2025-02-18 |
| Overdorf Michael | officer: EVP & CHIEF BUSINESS OFFICER | 2025-02-13 | S-Sale | 2.99 | 2025-02-18 |
| Lew Jennifer | officer: EVP & CHIEF FINANCIAL OFFICER | 2025-02-13 | S-Sale | 2.98 | 2025-02-18 |
| Yednock Ted | officer: EVP & CHIEF INNOVATION OFFICER | 2025-02-13 | S-Sale | 2.99 | 2025-02-18 |
| JONES WILLIAM A JR | director | 2025-01-09 | A-Award | 4.83 | 2025-01-10 |
| JONES WILLIAM A JR | 2025-01-09 | 0 | 2025-01-10 | ||
| Love Douglas | director, officer: PRESIDENT AND CEO | 2025-01-06 | M-Exempt | 1.4096 | 2025-01-08 |
| Love Douglas | director, officer: PRESIDENT AND CEO | 2025-01-06 | M-Exempt | 1.4096 | 2025-01-08 |
| Carson William H. | director | 2024-12-02 | P-Purchase | 5.33 | 2024-12-04 |
| Love Douglas | director, officer: PRESIDENT AND CEO | 2024-10-30 | M-Exempt | 1.8501 | 2024-11-01 |
| Love Douglas | director, officer: PRESIDENT AND CEO | 2024-10-30 | M-Exempt | 1.8501 | 2024-11-01 |
| Love Douglas | director, officer: PRESIDENT AND CEO | 2024-10-30 | M-Exempt | 1.8501 | 2024-11-01 |
| Yednock Ted | officer: EVP & CHIEF INNOVATION OFFICER | 2024-10-15 | M-Exempt | 1.8501 | 2024-10-17 |
| Yednock Ted | officer: EVP & CHIEF INNOVATION OFFICER | 2024-10-15 | S-Sale | 7.41 | 2024-10-17 |
| Yednock Ted | officer: EVP & CHIEF INNOVATION OFFICER | 2024-10-15 | M-Exempt | 1.8501 | 2024-10-17 |
| Carson William H. | director | 2024-10-01 | P-Purchase | 5.97 | 2024-10-02 |
| Yednock Ted | officer: EVP & CHIEF INNOVATION OFFICER | 2024-09-19 | S-Sale | 7.1 | 2024-09-20 |
| Yednock Ted | officer: EVP & CHIEF INNOVATION OFFICER | 2024-09-12 | S-Sale | 6.16 | 2024-09-16 |
| Yednock Ted | officer: EVP & CHIEF INNOVATION OFFICER | 2024-09-05 | S-Sale | 5.64 | 2024-09-06 |
| Carson William H. | director | 2024-09-03 | P-Purchase | 5.48 | 2024-09-04 |
| Yednock Ted | officer: EVP & CHIEF INNOVATION OFFICER | 2024-08-29 | S-Sale | 5.95 | 2024-08-30 |
| Carson William H. | director | 2024-08-01 | P-Purchase | 6.24 | 2024-08-05 |
| Overdorf Michael | officer: EVP & CHIEF BUSINESS OFFICER | 2024-07-15 | S-Sale | 6.02 | 2024-07-17 |
| Lew Jennifer | officer: EVP & CHIEF FINANCIAL OFFICER | 2024-07-15 | S-Sale | 6.03 | 2024-07-17 |
| Yednock Ted | officer: EVP & CHIEF INNOVATION OFFICER | 2024-07-15 | S-Sale | 6.02 | 2024-07-17 |
| Carson William H. | director | 2024-07-01 | P-Purchase | 5 | 2024-07-02 |
| WIGGANS THOMAS G | director | 2024-06-05 | A-Award | 6.79 | 2024-06-07 |
| Satter Muneer A | director, 10 percent owner: | 2024-06-05 | A-Award | 6.79 | 2024-06-07 |